Jeffrey Berns, MD, FASN|
Professor of Medicine
University of Pennsylvania School of Medicine
Robert Provenzano, MD.
Clinical Associate Professor
Wayne State University
St. Clair Specialty Physicians
Lynda Szczech, MD, MSCE, FASN
Professor of Medicine
Duke University Medical Center
This group of talks is
accredited for up to
AMA PRA Category 1 credits™. This group of talks has a single post-test,
which must be completed along with an evaluation form to obtain credit. The links to the post-test appear on the individual talk pages.
|| Date of Web Release: January 15, 2008
CME Credit Eligible Through: April 30, 2009
AMA PRA Category 1 Credits™:
Target Audiences: Physicians, researchers and trainees.
Method of participation: Listen to the talk, read the PubMed abstracts linked to data slides and talk references, take the post-test, read the abstracts linked to post-test answer feedback material.
This symposium will review current developments in the use of erythropoietic stimulating agents (ESA) in the treatment of anemia of chronic kidney disease (CKD). Clinical data will be reviewed evaluating the safety and benefits of ESA in CKD-related anemia including data on quality of life, cardiovascular outcomes, Hb targets, renal progression, and transfusion issues. New policy developments will be discussed based on the recent meeting of the Cardiovascular Renal Drug Advisory Committee (CRDAC). This will be followed by a discussion of ESA management principles including when to initiate treatment, what the Hb target should be, and how therapy should be monitored and titrated. Communication points for patients and healthcare community will be reviewed.
ACCREDITATION AND DESIGNATION STATEMENTS:|
The American Society of Nephrology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
CME Credit Designation Statement:
The American Society of Nephrology designates this educational activity for a maximum of
1.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
This official ASN symposium was supported by a restricted educational grant from
Ortho Biotech, Inc.
In accordance with the disclosure policies of the Accreditation Council for Continuing Medical Education (ACCME) and FDA guidelines, it is a policy at the ASN for individuals who are in a position to control the content of an educational activity to disclose to the activity participants: 1) the existence of all relevant financial relationships with any commercial interests or other relationships with the manufacturers of any commercial products/devices, or providers of commercial services, that relate to the content of their presentation/materials, or the commercial contributors of this activity, that could be perceived as a real or apparent conflict of interest; for this purpose we consider relationships of the person involved in the CME activity to include financial relationships of a spouse or partner and 2) the identification of a commercial product/device that is unlabeled for use or an investigational use of a product/device not yet approved.
| FACULTY DISCLOSURE STATEMENTS :|
Based on the disclosures provided, the ASN is responsible for identifying and resolving all conflicts of interest prior to presenting the educational activity to the learner. The intent of this policy is not to prevent expert faculty with relevant relationship(s) with commercial interest(s) from involvement in CME, but rather to ensure that ASN CME activities promote quality and safety, are effective in improving medical practice, are based on valid content, and are independent of control from commercial interests and free of commercial bias. In addition, all faculty members were instructed to provide balanced, scientifically rigorous, and evidence-based presentations.
(Faculty Disclosure Statement should
Faculty disclosures are posted on each individual talk page.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by FDA. The American Society of Nephrology and HDCN do not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved
indications, contraindications and warnings. Faculty disclosure about unlabeled or off-label use is posted on each individual talk page.
| DISCLOSURE OF UNLABELED USE:|
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
To complete this educational activity, the user will need Windows (XP or higher) or Macintosh (version 9.0 or higher) operating
software, a connection to the internet with a 28.8 kbps MODEM or better. The computer should have
an audio card with speakers. An audio player, either the Windows Media Player (download from www.microsoft.com) or
the Flash version 8.0 (download from www.adobe.com) is required, and either can be downloaded for free per instructions on the individual lecture pages. Flash version 8.0 is required for the full-screen slide version of the program. Acrobat Reader is required to print the CME certificate, and this can be download free from www.adobe.com.
For any questions concerning this specific activity please send an email to
or email@example.com, or call HDCN at 630-325-3276 during normal business hours, Chicago time (Central Standard Time).
For any general questions concerning ASN CME, please contact the American Society of Nephrology.